Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:4074413rdf:typepubmed:Citationlld:pubmed
pubmed-article:4074413lifeskim:mentionsumls-concept:C0034721lld:lifeskim
pubmed-article:4074413lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:4074413lifeskim:mentionsumls-concept:C0005388lld:lifeskim
pubmed-article:4074413lifeskim:mentionsumls-concept:C0521378lld:lifeskim
pubmed-article:4074413lifeskim:mentionsumls-concept:C0441889lld:lifeskim
pubmed-article:4074413lifeskim:mentionsumls-concept:C0806140lld:lifeskim
pubmed-article:4074413lifeskim:mentionsumls-concept:C1707520lld:lifeskim
pubmed-article:4074413lifeskim:mentionsumls-concept:C2349975lld:lifeskim
pubmed-article:4074413lifeskim:mentionsumls-concept:C1627358lld:lifeskim
pubmed-article:4074413pubmed:issue10lld:pubmed
pubmed-article:4074413pubmed:dateCreated1986-1-17lld:pubmed
pubmed-article:4074413pubmed:abstractTextIn female Wistar rats, epomediol (Clesidren) (30-300 mg/kg p.o.) induced a dose-dependent increase of bile flow and a concomitant enhancement in both unchanged drug and its mono-beta-glucuronide (M 3) biliary levels. Pretreatment with galactosamine (300 mg/kg i.p.) abolished the bile flow increase and resulted in a marked decrease of M 3 but not of the unchanged drug. Moreover, a highly significant correlation (r = 0.809) between M 3 biliary concentration and bile flow was found.lld:pubmed
pubmed-article:4074413pubmed:languageenglld:pubmed
pubmed-article:4074413pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:4074413pubmed:citationSubsetIMlld:pubmed
pubmed-article:4074413pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:4074413pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:4074413pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:4074413pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:4074413pubmed:statusMEDLINElld:pubmed
pubmed-article:4074413pubmed:issn0004-4172lld:pubmed
pubmed-article:4074413pubmed:authorpubmed-author:VenturaPPlld:pubmed
pubmed-article:4074413pubmed:authorpubmed-author:LuzzaniFFlld:pubmed
pubmed-article:4074413pubmed:authorpubmed-author:ScuriRRlld:pubmed
pubmed-article:4074413pubmed:authorpubmed-author:LumachiBBlld:pubmed
pubmed-article:4074413pubmed:issnTypePrintlld:pubmed
pubmed-article:4074413pubmed:volume35lld:pubmed
pubmed-article:4074413pubmed:ownerNLMlld:pubmed
pubmed-article:4074413pubmed:authorsCompleteYlld:pubmed
pubmed-article:4074413pubmed:pagination1548-9lld:pubmed
pubmed-article:4074413pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:4074413pubmed:meshHeadingpubmed-meshheading:4074413-...lld:pubmed
pubmed-article:4074413pubmed:meshHeadingpubmed-meshheading:4074413-...lld:pubmed
pubmed-article:4074413pubmed:meshHeadingpubmed-meshheading:4074413-...lld:pubmed
pubmed-article:4074413pubmed:meshHeadingpubmed-meshheading:4074413-...lld:pubmed
pubmed-article:4074413pubmed:meshHeadingpubmed-meshheading:4074413-...lld:pubmed
pubmed-article:4074413pubmed:meshHeadingpubmed-meshheading:4074413-...lld:pubmed
pubmed-article:4074413pubmed:meshHeadingpubmed-meshheading:4074413-...lld:pubmed
pubmed-article:4074413pubmed:meshHeadingpubmed-meshheading:4074413-...lld:pubmed
pubmed-article:4074413pubmed:meshHeadingpubmed-meshheading:4074413-...lld:pubmed
pubmed-article:4074413pubmed:year1985lld:pubmed
pubmed-article:4074413pubmed:articleTitleCorrelation of biliary epomediol-beta-glucuronide levels with bile flow enhancement in the rat.lld:pubmed
pubmed-article:4074413pubmed:publicationTypeJournal Articlelld:pubmed